Single use Bioreactors Market is calculated to reach USD 11.4 billion in 2029, registering 18.7 CAGR during 2022-2029 | Size, Trends & Forecast

Single use Bioreactors Market

Single use Bioreactors Market was valued at USD 2.9 billion in 2021 and is estimated to grow at a double digit CAGR 18.7% over the period, 2022-2029 and is projected to reach USD 11.4 billion in 2029

For Additional Insights, Click to Access Complete Report - https://www.gmiresearch.com/report/single-use-bioreactors-market-analysis-industry-research/

The factors driving the growth of Single use Bioreactors Market includes rising demand for pharmaceutical products around the world, expansion of the biologics industry, growing focus by companies on developing effective vaccines and increasing acceptance for single use bioreactors amongst small size organizations and start-ups. According to the report published by Statista, the Global Pharmaceutical Market has increased from USD 1.25 trillion in 2019 to USD 1.42 trillion in 2021, on-going demand for pharmaceutical products is expected to push the market growth in coming years. Moreover, the growing adoption of advanced technologies by manufacturers, improvements in the bioprocessing facilities, rising awareness amongst end-users about the benefits of single use bioreactors and increase in the launch of new products are some of the additional factors supplementing the Single Use Bioreactors Market Size. In addition, the increasing investments by leading players on research and development, mergers and collaboration between pharmaceutical companies, rapid urbanization, rising disposable incomes and growing population growth rates, are further contributing to the market growth.

However, the growth of Single use Bioreactors Market is hindered due to strict policies for manufacturing bioreactors.

The major players operating in the market are Merck KGaA, OmniBRx Biotechnologies, Pall Corporation, Applikon Biotechnology, Celltainer, Distek Inc., GE Healthcare, Sartorius AG and ABEC INC., among others.

Based on Cell Type, the Mammalian Cells segment is predicted to expand at a significant CAGR during the forecast period

Rise in the mammalian cell cultivation and increasing application of mammalian cell in the biopharmaceutical therapeutics development, are some of the factors responsible for the growth of the segment.

Based on Region, the North American region is projected to capture the largest market share during the forecast period

Rapid growth in the biopharmaceutical manufacturing, increasing focus on developing effective vaccines, presence of the leading players such as ABEC INC. and Pall Corporation, rising population growth rates and high per capita incomes, are some of the important factors augmenting the market growth in North America.

Key Developments

In 2019, Applikon Biotechnology officially publicized the launch of fully customizable single-use bioreactor using 3D printing technology which will expand company's product portfolio.

Market Segmentation

Segmentation by Type

Stirred Tank Single-use Bioreactors
Bubble Column Single-use Bioreactors
Wave Induced Single-use Bioreactors

Segmentation by Type of Molecule

Monoclonal Antibodies (MAbs)
Vaccine
Stem Cells
Gene-Modified Cells
Other Molecules

Segmentation by Cell Type

Mammalian Cells
Bacteria Cells
Yeast Cells
Others

Segmentation by Application

Research and Development
Process Development
Bioproduction

Segmentation by End-User

Pharmaceutical and Biopharmaceutical Companies
Academic and Research Institutes
Contract Research Organizations (CROs)
Contract Manufacturing Organizations (CMOs)
Others

Segmentation by Region

Asia Pacific
China
Japan
India
Rest of APAC

North America
United States of America
Canada

Europe
United Kingdom
Germany
France
Spain
Rest of Europe

RoW
Brazil
South Africa
Saudi Arabia
UAE

About GMI Research

GMI Research is a market research and consulting firm which provides market insights and intelligence across 12 major sectors helping our clients in making effective investment and business decisions.

Media Contact
Company Name: GMI RESEARCH
Contact Person: Sarah Nash
Email: enquiry@gmiresearch.com
Phone: Europe - +353 1 442 8820; US - +1 860 881 2270
Address: Dublin, Ireland
Website: https://www.gmiresearch.com/

Level 1, The Chase Carmanhall Road, Sandyford Industrial Estate, Dublin D18 Y3X2, Ireland

GMI Research's leadership team with extensive experience in research and consulting together with our research and domain expertise creates a strong value proposition to create solutions that addresses our clients business problems and add significant value to long lasting relationship.

This release was published on openPR.